Stakeholders Share Concerns On Combo Product Compliance Inspections
This article was originally published in The Gray Sheet
Executive Summary
Regulatory affairs specialists are questioning how FDA's policy on good manufacturing practices for combination products will transfer to field activities
You may also be interested in...
Office Of Combination Products Keeps Up Work To Clarify Regulatory Process
FDA's Office of Combination Products says it is working hard to provide industry with a clearer framework for bringing technologies that unite drugs, devices and biologics to market
Office Of Combination Products Keeps Up Work To Clarify Regulatory Process
FDA's Office of Combination Products says it is working hard to provide industry with a clearer framework for bringing technologies that unite drugs, devices and biologics to market
Combo Product Guidances On The March; Primary Mode Of Action Clarified
An FDA intercenter task force is working to finalize the proposed rule governing "primary mode of action" for combination products